US Department of Health and Human Services and SAMHSA's National Clearinghouse For Alcohol and Drug Information DHHS SAMHSA's National Clearinghouse For Alcohol and Drug Information
Photo Of Person One Photo Of Person Two Photo Of Person Three Photo Of Person Four
Drugs
Audiences
Issues
Publications
Newsroom
Calendar
Resources
Research

This Web site is a component of the SAMHSA Health Information Network.

Publications
Publications

Quick Find & Order
Top 50
Pubs in Series
Posters
Videos
Spanish
Drugs
Audiences
Issues

This Web site is a component of the SAMHSA Health Information Network.

  

Pregnant, Substance-Using Women
Treatment Improvement Protocol (TIP) Series 2

Chapter 2 -- Medical Guidelines for Pregnant, Substance-Using Women

Overview

Alcohol and other drug use during pregnancy can have detrimental effects -- both specific and nonspecific -- on the perinatal outcome. Specific effects of drug use can include facial dysmor- phology and organ system anomalies, such as alcohol- related birth defects. Pregnant women who use alcohol and other drugs are at an increased risk for preterm labor, thereby placing an already compromised fetus at increased risk. Nonspecific effects can include fetal growth retardation, resulting in small infants and decreased head circumference.20

Substance-using women and their infants are endangered by the spread of the human immuno- deficiency virus (HIV). The number of women who are infected with the virus from shared needles and multiple sexual contacts, and the number of their infants who are infected through mother-to-infant transmission of the virus, is increasing at an alarming rate.21 Every medical institution should follow Occu- pational Safety and Health Administration (OSHA) standards and universal precautions with respect to the blood and body fluids of all patients. To use such precautions only with known HIV-infected persons or known alcohol and other drug abusers places health care workers at great risk and fosters stereotyping.

In this time of excessive use and abuse of alcohol, cigarettes, cocaine, and other drugs, it is clear that wider recognition of such abuse -- as well as active intervention efforts -- are needed. It is also clear that, in addition to the policies and procedures usually followed prenatally and during labor, delivery, and postpartum, specific attention must be paid to pregnant, substance-using women and their infants.

It is not enough to provide obstetrical care to substance-using women; a holistic approach is essential. This approach should incorporate alcohol and other drug treatment, as well as help for all of the problems of daily living and survival that confront and confound these women.

Scope of the Guidelines

The following guidelines are designed to ensure that women receive the prenatal care, alcohol and other drug treatment, and comprehensive help they need to provide for their own health and that of their fetuses. In addition to obstetrical care, the guidelines address HIV-infected women, urine and/or blood toxicology, neonatal care, and nutrition.

 



NCADI Live Help
Send this Page to a Friend E-mail this Page
Printer Friendly Version Print this Page
Join the eNetwork Join the eNetwork
Contact Us Contact Us
Link to Us Link to Us
Home Home

Prevention Platform (new window)

Multimedia
 
Initiatives  |   Funding  |   Home
U.S. Department of Human and Health Services U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
Center for Mental Health Services
Center for Substance Abuse Prevention
Center for Substance Abuse Treatment
 
National Clearinghouse for Alcohol and Drug Information
About Us | Privacy | Accessibility | Disclaimer | Site Map | Awards |Customer Service
SAMHSA Home | Freedom of Information Act | Department of Health and Human Services | The White House | USA.gov